Intravenous immunoglobulin (IVIg)- impact of serum IgG peak-through differences for maintaining anti-inflammatory pathways in CIDP
Non-interventional study for the assessment of fatigue, depression, and safety in patients with CIDP under longterm treatment with Gamunex® 10% - GAMEDIS - GAMEDIS
100 Clinical Results associated with Grifols Deutschland GmbH
0 Patents (Medical) associated with Grifols Deutschland GmbH
100 Deals associated with Grifols Deutschland GmbH
100 Translational Medicine associated with Grifols Deutschland GmbH